Adherence to Antibacterial Therapy and Associated Factors in Lower Respiratory Infections in War-Affected Areas: A Randomized Controlled Trial

战争影响地区下呼吸道感染患者抗菌治疗依从性及相关因素:一项随机对照试验

阅读:1

Abstract

Background: Lower respiratory tract infections (LRTIs) are one of the leading causes of mortality. Pharmacist-led interventions can enhance adherence to antibiotics; the present study aims to determine adherence to the antibiotics prescribed for LRTIs and related factors. Methods: An individual randomized controlled trial was conducted with 1:1 (intervention = 205, control = 205) participants aged >18 years. The primary outcomes included adherence to therapy at weeks 1 and 2, awareness of antibiotic use, and appropriate discontinuation as prescribed. The secondary outcome measures were the overall clinical outcomes of the therapy and the effectiveness of educational interventions assessed at the final week 7 (overall assessment checked and treatment was not continued). The data were analyzed using different statistical methods, including descriptive statistics for data summarization, and inferential techniques were used. Results: Finally, 187 patients remained in the intervention group, and a total (n = 18) lost to follow-up. The awareness was significantly increased through pharmacist-led interventions (n = 106, 56.7%; p = 0.01), along with the factors leading to antibiotic resistance knowledge. Overall, adherence to antibacterial therapy for the LRTIs has improved (p ≤ 0.01), and a significant correlation exists between overall MMAS-8 mean scores and other demographic factors; interventions improved [0.441-2.151] with adherence (post-intervention). Higher adherence was found (p ≤ 0.05) among the participants in the intervention group compared to the control group and with (OR: 1.050; CI: 0.150-1.024) demographics (education, p = 0.05). Conclusions: Overall, the intervention group showed better awareness, understanding, and attitudes about antibiotics, and their adherence to antibiotic therapy improved significantly, along with the overall clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。